| Literature DB >> 17979227 |
Steven Halouska1, Ofelia Chacon, Robert J Fenton, Denise K Zinniel, Raul G Barletta, Robert Powers.
Abstract
D-Cycloserine (DCS) is only used with multidrug-resistant strains of tuberculosis because of serious side effects. DCS is known to inhibit cell wall biosynthesis, but the in vivo lethal target is still unknown. We have applied NMR-based metabolomics combined with principal component analysis to monitor the in vivo effect of DCS on Mycobacterium smegmatis. Our analysis suggests DCS functions by inhibiting multiple protein targets.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17979227 PMCID: PMC2566856 DOI: 10.1021/pr0704332
Source DB: PubMed Journal: J Proteome Res ISSN: 1535-3893 Impact factor: 4.466